Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01178957

Enrollment

Registered

2010-08-10

Start date

2012-04-30

Completion date

2013-04-30

Last updated

2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Type 1 diabetes, Very-Low-Density-Lipoprotein(VLDL), Hyperglycemia

Brief summary

The purpose of this study is to estimate the acute effect of hyperglycemia on Very-Low-Density-Lipoprotein-triglyceride(VLDL-TG) secretion.

Interventions

OTHERHyperglycemia

Hyperglycemia with a blood glucose of 15 mmol/L

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

1. Type 1 diabetes 2. Age 18-50 years

Exclusion criteria

1. Smoking 2. Alcohol abuse 3. Use of medications (except insulin in diabetics)

Design outcomes

Primary

Measure	Time frame	Description
Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) secretion	8 hours	Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) kinetics over a single study day

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026